Home MarketFortis Healthcare Ltd.

Fortis Healthcare Ltd. Stock Info: As on 2017-05-26 15:59:13

Nse

202.75

0.20(0.10%)
Change%
52 Week Range
142.25
9.00
228.95
3.00
Open205.10
Day's Range182.30 - 222.81
Value Traded (in ₹ Cr.) 43.41

Bse

202.75

0.05(0.02%)
Change %
52 Week Range
142.60
9.00
230.90
3.00
Open205.00
Day's Range182.43 - 222.97
Value Traded (in ₹ Cr.) 6.24

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 270,791,948.00 52.30%
Mutual Funds/UTI 303,659.00 0.06%
FII 178,634,800.00 34.50%
Employee 0.00 0.00%
Public 40,238,578.00 7.77%
Government 0.00 0.00%
Others 26,026,912.00 5.03%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 13.29
Basic EPS (Rs.) -1.59
Cash EPS -1.04
BVPerShare Excl 77.91
Operating Revenue 13.21
PBDITPerShare 0.63
Dividend 0.00
NPPerShare -1.59
Current Ratio 1.85
Quick Ratio 1.84
PriceToBV 2.25
Earnings -0.01
PBDIT Margin 4.80
PBT Margin -12.01
NP Margin -12.01
Return On Assets -1.49
Retention Ratios 0.00
Parameter Mar-16 (₹ Cr.) Yoy%change
Total Income 758.83
Total Expenses 817.00
EBITDA 29.39
PBT -73.51
PAT -73.51
Net Income -73.51
More
Parameter Mar-16 (₹ Cr.) 6M % change
Total Income 376.34
Total Expenses 367.99
EBITDA -5.60
PBT -30.78
PAT -30.78
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-16 (₹ Cr.) Yoy%change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Parameter Mar-16 (₹ Cr.) 6M % change
Total share capital 463.13
Net worth 3,608.27
Investments 2,635.50
Total Liability 4,909.37
Total debt 1,044.54
Net block 349.23
Total Assets 4,909.37
Company Curr Price Prev. Close Change% W's Low/High

Apollo Hospitals Enterprise Ltd.

1217.35 1205.25 1
1196.31272.9

Dr. Lal Pathlabs Ltd.

893.7 898.25 -0.51
875914

Healthcare Global Enterprises Ltd.

253 252.65 0.14
250264.95

Indraprastha Medical Corporation Ltd.

53.75 52.95 1.51
52.6556.25

Kovai Medical Center and Hospital Ltd.

641.65 624.85 2.68
629.9649.9

Lotus Eye Hospital and Institute Ltd.

30.3 30.95 -2.1
29.1532.25

Marico Kaya Enterprises Ltd.

1547.05 1582.55 -2.24
1535.051589
Company Curr Price Prev. Close Change% W's Low/High

ADS Diagnostic Ltd.

11.34 10.8 0
11.3411.34

Apollo Hospitals Enterprise Ltd.

1233 1204.2 2.39
11981272.25

Birla Pacific Medspa Ltd.

0.28 0.27 0
0.270.28

CDR Health Care Ltd.

7.58 2.6 0
7.227.58

Chennai Meenakshi Multispeciality Hospital Ltd.

12.87 12.26 4.98
10.612.87

Dhanvantri Jeevan Rekha Ltd.

49 49.05 -0.1
44.4551.5

Dolphin Medical Services Ltd.

1.45 1.39 4.32
1.331.45
More
Parameter Mar-16(in ₹ Cr.)
Cash from operating activities -693.61
Cash from investing activities 379.12
Cash from financing activities 317.58
Net change in cash 3.09

Stock Held By Mutual Fund Schemes

Scheme Holding (%)
Birla Sun Life Pure Value Fund 1.95%
Kotak Equity Arbitrage Fund - Regular Plan 0.37%
Edelweiss Arbitrage Fund 0.39%
Axis Enhanced Arbitrage Fund 1.14%
Birla Sun Life Dividend Yield Plus 0.46%
Birla Sun Life Special Situations Fund 1.05%

Tech Mah Q4 net falls 30.2% qoq to Rs 589.69 cr

IT services firm Tech Mahindra Ltd on Friday reported a drop of 30.2 per cent in its consolidated net profit after tax at Rs 589.69 crore sequentially for the March quarter of FY17, as compared to Rs 844.86 crore in December quarter. “The consolidated net profit of the IT major stood at Rs 876.14 crore during the same quarter a year ago,” Tech Mahindra Ltd said in a filing to the Bombay Stock Exchange on May 26, 2017. The consolidated total income of Tech Mahindra witnessed a marginal increase of 0.3 per cent to Rs 7,732.89 crore sequentially in Q4 FY17, against Rs 7,712.68 crore in previous quarter. Further, on y-o-y basis, its total income grew by 9.9 per cent from Rs 7,039.03 crore in Q4 FY16. Commenting on the performance, Tech Mahindra Ltd, Vice Chairman, Vineet Nayyar said, “Information technology, the world over is going through a major shift with demand patterns changing constantly. Most businesses are also battling the geopolitical uncertainties and as a digital transformation company, we see these as huge opportunities in the future.” In dollar terms, its net profit down 29.3 per cent q-o-q while 30 per cent y-o-y at USD 89.1 million during the quarter under review. On the other hand, its revenue grew by 1.3 per cent qoq and 10.6 per cent y-o-y at USD 1,131.2 million in Q4 FY 17. The company’s board has recommended a dividend of Rs 9 per share on par value of Rs 5 (180 per cent) for the financial year ended March 31, 2017, subject to approval by the members of the company at the forthcoming AGM. Meanwhile, shares of the company closed at Rs 429.35 apiece, up 0.61 per cent, from previous close on BSE.

26-05-2017 18:20

Tata Chemicals Q4 net profit up 32% at Rs 343 cr

Tata Chemicals today reported a 31.82 per cent increase in consolidated net profit at Rs 343.02 crore in the fourth quarter of 2016-17 fiscal even as income remained down. Its net profit stood at Rs 260.21 crore in the year-ago period, the company said in a BSE filing. Total income declined to Rs 3,079.47 crore in the January-March quarter of the 2016-17 fiscal from Rs 3,618.14 crore in the year-ago period. However, expenses remained lower at Rs 2,733.96 crore as compared to Rs 3,310.56 crore in the said period. For the FY 2016-17, net profit rose to Rs 1,234.10 crore from Rs 1,001.11 crore in the previous fiscal. The board has recommended a dividend of Rs 11 per ordinary share of Rs 10 each for the 2016-17 fiscal, subject to the approval of the shareholders at the ensuing annual general meeting of the company. The dividend, if approved, will be paid on and from August 11, 2017. Tata Chemicals, a Tata group company, is engaged in manufacturing of chemicals, salt and fertilisers. It also sells pulses and spices under Tata Sampann brand. The firm is also into water purifier business. Meanwhile, shares of the company closed trading at Rs 612.10 apiece, down 0.46 per cent from the previous close on BSE.

26-05-2017 16:53

Gujarat State Petronet Q4 net rises 27.7% to Rs 126.98 cr

Gujarat State Petronet Ltd (GSPL) has reported a surge of 27.7 per cent in its standalone net profit after taxes (PAT) at Rs 126.98 crore for the fourth quarter ended March 31, 2017. “The standalone PAT of the company stood at Rs 99.45 crore during the same period a year ago,” said Gujarat State Petronet Ltd in a filing to the Bombay Stock Exchange. Further, the standalone total income of the company grew by 10.8 per cent to Rs 271.94 crore during Q4 2016-17, as compared to Rs 245.39 crore during the same period last year. The company’s board has recommended a dividend of Rs 1.50 per share of Rs 10 each (i.e. at the rate of 15 per cent) for the FY 2016-17. Meanwhile, shares of the company closed at Rs 170.30 apiece, down 1.99 per cent, from previous close on BSE.

26-05-2017 16:04

HPCL Q4 net surges 31% at Rs 1,819 cr

State-run Hindustan Petroleum Corporation Ltd (HPCL) on Friday reported a 31.04 per cent growth in its standalone net profit at Rs 1,818.79 crore for the fourth quarter ended March 31, 2017. “The company had posted standalone net profit of Rs 1,387.91 crore in the year ago period,” said HPCL in a filing to Bombay Stock Exchange. The standalone total revenue of the company rose by 21.71 per cent to Rs 59,183.49 crore in Q4 FY17 compared to Rs 48,625.27 crore in Q4 FY16. During the quarter under review, domestic sales was flat at 8.76 million metric tonnes while export sales doubled to 0.1 million metric tonnes compared to the previous quarter. For FY 2016-17, the company has posted net profit of Rs 6,208.80 crore against total revenue of Rs 215,317.71 crore. The company in a separate release said that its board has recommended a final dividend of Rs 1.10 per share of Rs 10 each for the Financial Year 2016-2017 subject to the approval of the shareholders at the ensuring Annual General Meeting. The final dividend shall be paid within 30 days from the date of its declaration at the AGM. Meanwhile, shares of company closed day’s trade at Rs 567.45 apiece, up 11.43 per cent, on the BSE.

26-05-2017 16:04

ITC Q4 net rises 12% at Rs 2,669 cr

ITC, India’s leading fast-moving consumer goods company, on Friday reported a 12.13 per cent growth in its standalone net profit at Rs 2,669.47 crore for the fourth quarter ended March 31, 2017, helped by spurt in revenue from cigarette segment. “The company had posted standalone net profit of Rs 2,380.68 crore in the year ago period,” said ITC in a filing to Bombay Stock Exchange. The standalone total revenue of the company rose by 4.8 per cent to Rs 15,008.82 crore in Q4 FY17 compared to Rs 14,138.78 crore in Q4 FY16. During the quarter under review, cigarette and other FMCG products posted revenue of Rs 11,840.70 crore, compared with Rs 11,256.24 crore-revenue in the year-ago quarter. Among others, businesses such as hotels, agri business, paperboards and packaging increased to Rs 15,518.44 crore from Rs 14,741.05 crore in the year ago period. The company in a separate release said that its board has recommended dividend of Rs 4.75 per ordinary share of Rs 1 each for the financial year ended 31st March, 2017, subject to declaration of the same by the Members at the 106th Annual General Meeting of the Company convened for Friday, 28th July, 2017. The dividend, if declared, will be paid on Monday, 31st July, 2017 to those Members entitled thereto. Boosted by the strong Q4, shares of company were trading 0.94 per cent higher at Rs 653.00 apiece on the BSE at 15:05 hours.

26-05-2017 15:49

Fortis Healthcare - Notice of Postal Ballot

Fortis Healthcare Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.

26-May-2017 05:40 PM

Fortis Healthcare - Notice of Postal Ballot

Postal Ballot Notice - To increase the shareholding limit for Registered Foreign Institutional Investors (FIIs) from 24% upto an aggregate limit of 74% of the paid-up equity share capital of the Company

26-May-2017 05:28 PM

Fortis Healthcare - Updates

This is to inform that the Board of Directors have today, approved a proposal to enhance the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company.



The said increase is subject to the approval of the shareholders and such statutory/ regulatory approvals as may be necessary in this regard.



Further, the Board has also approved the Notice of Postal Ballot along with Appointment of scrutinizer for the same.

25-May-2017 07:01 PM

Fortis Healthcare - Board Meeting On May 30, 2017

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that a meeting of the Board of Directors of the Company will be held on Tuesday, May 30, 2017 to, inter-alia, consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2017. Further, the trading window of the Company for dealing in securities of the Company will remain closed from May 23, 2017 to June 1, 2017 (both days inclusive).

22-May-2017 02:59 PM

Fortis Healthcare - Intimation Of Proceedings And Results Of Tribunal Convened Meetings Under The SEBI (Listing Obligations A

The Equity Shareholders' Meeting was convened on April 27, 2017, as per the order of the Chandigarh Bench of the National Company Law Tribunal dated February 21, 2017, for approving the proposed Scheme ('Order'). Separately, the unsecured creditors of the Company approved the Scheme in the meeting of unsecured creditors convened on April 26, 2017, as per the Order. The voting results of the same are enclosed.

28-Apr-2017 05:48 PM

Fortis Healthcare - Notice of Postal Ballot

Fortis Healthcare Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.

26-May-2017 05:40 PM

Fortis Healthcare - Notice of Postal Ballot

Postal Ballot Notice - To increase the shareholding limit for Registered Foreign Institutional Investors (FIIs) from 24% upto an aggregate limit of 74% of the paid-up equity share capital of the Company

26-May-2017 05:28 PM

Fortis Healthcare - Updates

This is to inform that the Board of Directors have today, approved a proposal to enhance the ceiling limit on total holdings of FII/SEBI approved sub-accounts of FIIs, FPIs, QFIs, Non Resident Indians (NRIs) and Person of Indian Origin (PIO) under the Portfolio Investment Scheme upto 74% of the paid-up equity capital of the Company.



The said increase is subject to the approval of the shareholders and such statutory/ regulatory approvals as may be necessary in this regard.



Further, the Board has also approved the Notice of Postal Ballot along with Appointment of scrutinizer for the same.

25-May-2017 07:01 PM

Corporate Details

About Management

The registered office of the Company was initially situated at 25, Nehru Place, New Delhi 110 019, India. Pursuant to a Board resolution dated September 16, 2003 the registered office was shifted to B- 9, Maharani Bagh, New Delhi 110 065, India. Subsequently, pursuant to Board resolution dated February 10, 2006 the registered office of the Company was shifted to Piccadily House, 275- 276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi 110 065, India, which is the current Registered Office. Scheme of merger/amalgamation between Fortis Medical Centre Holdings Limited and the Company dated October 7, 2005: The High Court of Delhi, through its order dated October 7, 2005 in respect of the company petition (C.P. No: 240/2005 and 241/2005) approved the scheme of amalgamation/merger between the Company and Fortis Medical Centre Holdings Limited ("FMCHL"), and which at the time of amalgamation was our board controlled subsidiary, with effect from April 1, 2004 ("Scheme"). Salient features of the Scheme: The principal terms of the Scheme, as sanctioned by the High Court of Delhi, are set forth below: The entire undertaking and business, all properties, tangible and intangible assets including trademarks, patents, design, copyrights, investments, approvals, licenses, tax benefits, pending projects, debts, liabilities and obligations, including income tax liabilities accrued or to accrue in FMCHL was transferred to the Company with effect from April 1, 2004. Pursuant to the Scheme, Fortis Hospital, Amritsar was transferred to the Company. However, the transfer of the aforesaid was subject to the existing charges or hypothecation in respect of the assets of FMCHL. All the staff, workmen and employees of FMCHL in employment on the date immediately preceding December 23, 2005 (i.e., the date on which a certified copy of the order of the High Court of Delhi was filed with the RoC) became the employees of the Company without any break or discontinuity in service and on conditions not less favourable than those subsisting at FMCHL. In consideration of the transfer and vesting of the undertaking and the assets and liabilities of FMCHL and in consideration of the mutual covenants agreed to in the Scheme, the Company agreed to allot the Equity Shares to the existing shareholders of FMCHL, in the ratio of 1:4 (i.e., one Equity Share in exchange of every four equity shares of FMCHL of Rs. 10 each). In compliance with the Scheme, the Company allotted 520,000 Equity Shares to the shareholders of erstwhile FMCHL on February 10, 2006. Major Events: Year Event June 2001 Commissioning of Fortis Hospital, Mohali. August 2003 Inauguration and commissioning of Fortis Hospital, Amritsar. October 2003 Executed an agreement with Seth Jessa Ram and Bros Charitable Hospital Trust for the operation and management of Jessa Ram Hospital, New Delhi. August 200 Commissioning of Fortis Hospital, Noida. September 2005 Acquired 90% of the equity share capital of Escorts Heart Institute and Research Centre Limited resulting in the acquisition of EHCL, EHSSIL, EHSSHL and EHRCL. October 2005 Signed an agreement with Jeewan Mala Hospital Private Limited for the operation and maintenance of Jeewan Mala Hospital, New Delhi. January 2006 Signed an agreement with Sunrise Medicare Private Limited for the operation and management of Fortis La Femme, New Delhi, and acquisition of 5% equity interest in Sunrise Medicare Private Limited, with an option to acquire additional equity shares. January 2006 Signed an agreement with Khalil Public Welfare Trust for the operation and maintenance of Khyber Medical Institute, Srinagar. March 2006 Acquired 99.99% of the paid up equity share capital of International Hospital Limited resulting in the acquisition of Fortis Hospital, Noida. March 2006 Acquired 100.00% of the paid up equity share capital of Oscar Bio-Tech Private Limited. 2004 -Fortis inks deal with Jessa Ram Hospital to takeover the management of the hospital 2005 -Fortis Hospital rolls out Golden Age Club -Fortis buys Escorts Heart -Fortis Healthcare signs $33.33m pre-IPO deals The Company was incorporated on February 28, 1996 as Rancare Limited under the Companies Act. Subsequently on June 20, 1996 our name was changed to our present name-Fortis Healthcare Limited. The Company received the certificate of commencement of business on July 1, 1996. 2006 -Fortis Healthcare to buy majority stake in Trehan`s Medicity -Fortis Healthcare signs $33.33m pre-IPO deals 2007 -Fortis HealthWorld has joined hands with US hearing aid maker Starkey for its Audible range and is looking to soon offer dental services at its Health stores too. -Colgate-Palmolive India, the market leader in toothpaste in India, declared the acquisition of three domestic companies in south India recently. The company purchased 75 per cent equity in Advanced Oral Care Products (Goa), Professional Oral Care Products (Goa) and SS Oral Hygiene Products (Hyderabad). -Fortis Healthcare acquires Hiranandani Hospital 2008 -Fortis Healthcare Ltd has informed that the Board of Directors of the Company at its meeting held on January 23, 2008, inter alia, has approved change in registered office of the Company from "Piccadily House, 275-276, 4th Floor, Captain Gaur Marg, Srinivas Puri, New Delhi - 110065" to "Escorts Health Institute And Research Centre, Okhla Road, New Delhi - 110025". 2009 -Fortis completes Wockhardt Hospital Acquisition -Fortis signs $15 mn outsourcing deal with HCL -Fortis Healthcare Ltd Issues Rights in the Ratio of 2:5 2010 - 25% stake in Parkway holdings, Asia's largest private healthcare provider. - "Fortis Healthcare infuses USD 100 Million". - Fortis increases stake in Parkway. - Government of Singapore Investment Corp (GIC) to join hands with Fortis at strategic level. - Fortis Healthcare has entered into a pact with two hospitals in Dubai and Tanzania to set up specialised medical facilities. - Company has announced its foray into Speciality Medical Centres focused on the management of diabetes, metabolic diseases and endocrinology. 2011 - A Memorandum of Understanding has been signed by Fortis Healthcare Ltd with the University of Utah to develop courses for Emergency Medical Technicians. - Through its wholly owned subsidiary, has entered into an agreement with Cauvery Hospital Limited, Mysore, wherein Fortis will set up, operate and manage a Cardiac Centre in the hospital. - The name of Fortis Healthcare Limited shall be changed to Fortis Healthcare (India) Limited w.e.f. April 11, 2011. - "Fortis Healthcare ties up with TotipotentRX to set up Stem Cell Therapy Centres". - Fortis Healthcare (India) Ltd has announced that it will buy 86 per cent stake in Super Religare Laboratories Ltd (SRL) . - Fortis Healt - Fortis announces new hospitals in Hyderabad and Agra. 2012 - "Fortis to get Rs. 3700 Mn Equity infusion in SRL through IFC and NYLIM Jacob Ballas India". - Fortis Healthcare raises around S$510 mn through Singapore IPO. -Company has changed its name from Fortis Healthcare (India) Ltd. to Fortis Healthcare Ltd. 2013 -"Fortis launches its Flagship Hospital, One of the First of its Kind in Asia Bridges the gap for expert talent, trans-disciplinary, quaternary care". -"Fortis to divest stake in Quality Healthcare to Bupa for US$ 355 million Intensifies Focus on Healthcare Delivery in India". 2014 -"Fortis launches state of the art, multi super-specialty hospital in Ludhiana". 2016 -Fortis Healthcare has fully acquired Religare Health Trust Trustee Manager for USD 14.9 million (about Rs 100 crore). -Fortis group gets CCI nod for internal reorganisation. -Fortis Healthcare First in India to Monitor and Publish Clinical Outcomes for Cardiology. -Fortis Healthcare launches National helpline for students and parents to help deal exam stress.

Registered Office

Fortis-Escorts Hospital: 2nd Floor, Coronation Hospital, Curzon Road,

,,,      ,

Registrar Details

Karvy Computershare Private Ltd.